Granulocyte colony-stimulating factor (G-CSF) downregulates its receptor (CD114) on neutrophils and induces gelatinase B release in humans

British Journal of Haematology

Volumn 111, Issue 1, 2000, Pages 314-320

  Jilma, Bernd ^a   Hergovich, Nicole ^a   Homoncik, Monika ^a   Jilma Stohlawetz, Petra ^a   Kreuzer, Claudia ^a   Eichler, Hans Georg ^a   Zellner, Maria ^a   Pugin, Jerome ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

CD114; CD11b; G CSF; G CSF receptor; Gelatinase B

Indexed keywords

CD 114 RECEPTOR; DEXAMETHASONE; GELATINASE A; GELATINASE B; PLACEBO; RECEPTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN EXPERIMENT; MALE; NEUTROPENIA; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR DOWN REGULATION;

ANTIGENS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; NEUTROPHILS; PROSPECTIVE STUDIES; PROTEIN BINDING; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; VON WILLEBRAND FACTOR;

EID: 0033764001     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02320.x     Document Type: Article

References (37)

1. Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures
2. A functional granulocyte colony-stimulating factor receptor is required for normal chemoattractant-induced neutrophil activation
3. Human neutrophil granules and secretory vesicles
4. Neutrophil transfusions: Kinetics and functions of neutrophils mobilized with granulocyte-colony stimulating factor and dexamethasone
5. The role of metalloproteinases and adhesion molecules in interleukin-8-induced stem-cell mobilization
6. Processing of tumour necrosis factor-alpha precursor by metalloproteinases
7. Different membrane expression of CD11b and CD14 on blood neutrophils following in vivo administration of myeloid growth factors
8. Perturbed granulopoiesis in mice with a targeted mutation in the granulocyte colony-stimulating factor receptor gene associated with severe chronic neutropenia
9. Endotoxin down-modulates granulocyte colony stimulating factor receptor (GCSFR, CD114) on neutrophils in humans
10. Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34 (+) cells and their transmigration through reconstituted basement membrane
11. Evaluation and comparison of three mobilization methods for the collection of granulocytes
12. Effects of desmopressin on circulating P-selectin
13. Dexamethasone down-regulates the expression of L-selectin on the surface of neutrophils and lymphocytes in humans
14. Glucocorticoids dose dependently increase plasma levels of granulocyte colony stimulating factor in man
15. Circadian variation of granulocyte colony stimulating factor levels in man
16. Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin
17. Re-expression of functional P-selectin molecules on the endothelial cell surface by repeated stimulation with thrombin
18. Desmopressin induces endothelial P-selectin expression and leukocyte rolling in post-capillary venules
19. Expression and dynamic modulation of the human granulocyte colony-stimulating factor receptor in immature and differentiated myeloid cells
20. A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers
21. The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo
22. Production and characterization of recombinant active mouse gelatinase B from eukaryotic cells and in vivo effects after intravenous administration
23. Development of neutrophilia by serially increasing doses of dexamethasone
24. Receptors for colony-stimulating factors
25. The molecular basis of leukocytosis
26. Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men
27. Effects of repeated administration of granulocyte colony-stimulating factor (G-CSF) on neutrophil counts, plasma cytokine, and cytokine receptor levels
28. Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9)
29. Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators
30. Treatment of normal individuals with granulocyte-colony- stimulating factor: Donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells
31. Blood counts in healthy donors 1 year after the collection of granulocyte-colony-stimulating factor-mobilized progenitor cells and the results of a second mobilization and collection
32. Expression of neutrophil antigens after 10 days of granulocyte-colony-stimulating factor
33. Ex vivo neutrophil function in response to three different doses of glycosylated rHuG-CSF (Lenograstim)
34. Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment
35. Crossover study of the haematological effects and pharmacokinetics of glycosylated and non-glycosylated G-CSF in healthy volunteers
36. The effect of granulocyte colony-stimulating factor (G-CSF) on the degranulation of secondary granule proteins from human neutrophils in vivo may be indirect
37. Differential effects of granulocyte-and granulocyte-macrophage colony-stimulating factors (G- and GM-CSF) on neutrophil adhesion in vitro and in vivo